Kovai Medical Center & Hospital Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 4.59% vs 4.75% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 2.85% vs 4.63% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 1.14% vs 4.69% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is -4.69% vs 6.01% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Kovai Medical With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

390.74

137.29

253.45

184.61%

Other Operating Income

1.26

0.00

1.26

Total Operating income

392.00

137.29

254.71

185.53%

Raw Material Cost

106.72

27.58

79.14

286.95%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

75.92

27.80

48.12

173.09%

Power Cost

0.00

Manufacturing Expenses

54.78

0.00

54.78

Selling and Distribution Expenses

0.00

Other Expenses

47.57

54.96

-7.39

-13.45%

Total Expenditure (Excl Depreciation)

284.99

110.34

174.65

158.28%

Operating Profit (PBDIT) excl Other Income

107.01

26.95

80.06

297.07%

Other Income

6.41

6.15

0.26

4.23%

Operating Profit (PBDIT)

113.42

33.10

80.32

242.66%

Interest

8.74

0.19

8.55

4,500.00%

Exceptional Items

0.00

Gross Profit (PBDT)

104.68

32.91

71.77

218.08%

Depreciation

26.78

6.32

20.46

323.73%

Profit Before Tax

77.89

26.60

51.29

192.82%

Tax

19.03

5.96

13.07

219.30%

Provisions and contingencies

0.00

Profit After Tax

58.86

20.64

38.22

185.17%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

58.86

20.64

38.22

185.17%

Equity Capital

10.94

96.35

-85.41

-88.65%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

53.80

2.14

51.66

2,414.02%

Diluted Earnings per share

53.79

2.14

51.65

2,413.55%

Operating Profit Margin (Excl OI)

27.39%

19.63%

0.00

7.76%

Gross Profit Margin

26.79%

23.97%

0.00

2.82%

PAT Margin

15.06%

15.03%

0.00

0.03%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 390.74 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 4.59% vs 4.75% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 13.70% vs 13.64% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 58.86 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 2.85% vs 4.63% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 16.12% vs 16.77% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 107.01 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 1.14% vs 4.69% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 12.05% vs 12.01% in Sep 2024

Quarterly - Interest

Interest 8.74 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -4.69% vs 6.01% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 6.07% vs -0.24% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 27.39%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024